Skip to content

Ketogenic Diets as an Add-on Therapy in Infantile spasms: A Prospective, Multicenter Pilot Study

Ketogenic Diets as an Add-on Therapy in Infantile spasms: A Prospective, Multicenter Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPN-17014209
Enrollment
Unknown
Registered
2017-12-29
Start date
2017-07-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile spasms

Interventions

Experimental:specially-formulated very low carbohydrate meals (KD) with meidication
Control group:General diet with routing treatment

Sponsors

Peking University 1st hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of infantile spasm conforms to criteria of ILAE (2001): epileptic spasms, hypsarrhythmia pattern on electroencephalography, delayed motor and mental development; 2. Patients with poor or recurrent outcomes after trying ACTH or corticosteroids for more than 14 days with dosage more than 1.5mg/d. And the medicine has been taken off for more than 14 days; 3. Aged 3-36 months; 4. Seizure frequency (at least 4 cluster per month); 5. No previous treatment with ketogenic diet; 6. The guardian agrees to use ketogenic diet, collect blood samples from patents for sequencing analysis and sign a consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe digestive, cardiovascular, respiratory, urinary, liver or genetic metabolic disease, and congenital immunodeficiency disease; 2. Severe vomiting; 3. Active stage of febrile or infectious diseases; 4. Metabolic disease contraindicating use of the ketogenic diet e.g. pyruvate carboxylase deficiency, Pyruvate carboxylase de?ciency, porphyria, long-chain acyl dehydrogenase de?ciency (LCAD), medium-chain acyl dehydrogenase deficiency (MCAD) from previous medical investigation and screening at baseline; 5. Severe food refusal; 6. Patients who had undergone transplantation, stem cell therapy and transfused allogeneic blood products within half a year and the patients have hemolytic disease; 7. Definite surgical focus was identified and the patient has indications for the surgical treatment.

Design outcomes

Primary

MeasureTime frame
Seizure Frequency;

Countries

China

Contacts

Public ContactWu Ye

Peking University 1st hospital

likejipku@126.com+86 13520756697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026